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ABSTRACT 
Traditional medicinal system relies on the knowledge and clinical expertization of physicians to regulate the indigenous medicinal 
system for the sake of well being to humans. Considering the bioavailability issues of phytoconstituents, in this review, we have 
focused on the various aspects of phytosomes in drug delivery. Phytosome technology is used to enhance the absorption of poorly 
absorbed lipid soluble active constituents from the herb extracts. So, the article covers a brief introduction of phytosomes, their 
method of development along with its formulation and evaluation parameters such FTIR, NMR etc. Different types of dosages forms 
are described in the review, merits and demerits are also discussed along with diagrammatic representation of phytosome 
development technique. So, the article is the direction for future research to increase the absorption of phytoconstituents. 
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INTRODUCTION  
Traditional medicines rely on the basis of knowledge 
and clinical experience of the practitioners for 
indigenous systems of medicine. Historically, many 
infectious diseases have been treated with the help of 
herbals. The traditional medicine is increasingly 
solicited through the traditional practitioners and 
herbalists in the treatment of infectious diseases. Among 
the remedies used, plant drugs constitute an important 
part. Current status of scientific investigations has 
highlighted the importance and the contribution of many 
plant families, i.e. Asteraceae, Liliaceae, Apocynaceae, 
Solanaceae, Caesalpinaceae, Rutaceae, Piperaceae, 
polypodiaceae 
1
. From the very beginning, the most 
important parameter is solubility and absorption to 
increase the bioavailability of phytoconstituents to 
obtain more efficacies of the herbal drugs. It has been 
observed that most of the therapeutically active plant 
constituents such as the flavonoids and terpenoids, 
aglyconglycosides are of highly polar in the nature 
hence they are water soluble molecules. Thus, these are 
poorly absorbed due to their poor lipid solubility. Poor 
absorption might be due to their large molecular size 
which cannot absorb by passive diffusion. This limits 
their ability to pass across the lipid‐rich biological 
membranes and thus resulting in poor bioavailability. 
There are several techniques available to overcome these 
problems, viz cosolvents, inclusion of solubility and
 
bioavailability enhancers, structural modification and 
entrapment with lipophilic carriers 
2-8
. Although even 
standardized plant materials having low solubility in the 
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lipids or possess highly polar nature to assimilate as lipid 
profile. 
A new approach named as phytosome is developed 
which indicates like as “plant” and “cell” [phyto means 
plant and some means cell like]
 9-11
. The phytosome 
technology, developed by Indena S.P.A. in Italy, 
markedly enhances the bioavailability of selected 
phytomedicines, by incorporating phospholipids into 
standardized extracts and so vastly improve their 
absorption and utilization 
12
. These novel preparations 
make polar phytocells to obtain highly lipid compatible 
molecular complexes with enhanced absorption and 
bioavailability. Different chemical constituents obtained 
from medicinal plants are water soluble phytoactive such 
as flavonoids, glycosides, terpenoids are delivered using 
phytosome technique. Because of the water soluble 
nature, herbal extract lipophilic outer layer phytosomes 
have better absorption and can show better 
bioavailability profile than the conventional herbal 
extracts containing dosage form. These are produced by 
a process whereby the standardized plant extract or its 
constituents are bound to phospholipids, mainly 
phosphatidylcholine, producing a lipid compatible 
molecular complex formation of chemical bonds 
between phosphatidylcholine molecule and 
phytoconstituent produces better stability profile 
6
. It is 
laterally meant as a phytolipids delivery system 
9 
also 
known as herbosomes 
10
. It is a newly introduced 
patented technology 
13
, which forms a bridge between 
the convectional drug delivery system and novel drug 
delivery system for incorporating standardized 
phytoextracts or water soluble phytoconstituents into 
phospholipids to produce lipid compatible molecular 
complexes to obtain greater absorption and 
bioavailability to acquire the higher therapeutic effects 
of poorly absorbed water soluble phytoconstituents. 
Thus, most useful application of phytosomes is the 
absorption of drugs in the form of reversible complexes 
with phospholipids, which proved their higher and long 
lasting anti-inflammatory and vasokinetic activities due 
to complexation of active ingredients with phospholipids 
than those observed after administration of the same 
amount of substance in free form 
9-13
.  
Formulation approach 
Phytosomes are the reaction product of a stoichiometric 
amount of phospholipid (α-Lysophosphatidylcholine, α-
phosphatidylcholine) and standardized plant extract in 
the presence of  a solvent which is incapable of acting as 
a proton donor (aprotic solvent). α-
lysophosphatidylcholine, α-phosphatidylcholine, α-
phosphatidylethanolamine, α-phosphatidic acid are the 
most commonly used as phospholipid with herbal 
standardized plant extracts. α-lysophosphatidylcholine is 
a bifunctional chemical constituent in which 
phosphatidyl fraction is lipophilic in nature which 
denotes the head of the bifunctional compound and the 
hydrophilic choline fraction is the tail of the bifunctional 
compound. Thus, choline part of α-
lysophosphatidylcholine bounds to the hydrophilic 
phytoconstituents, while the lipid soluble phosphatidyl 
part join the choline bound complex. So, it leads to form 
a phyto-phospholipid complex to enhance lipid 
solubility. A chemical bond plays a vital role to bind the 
choline head with polar phytoconstituents. Thus, the 
phytosomes technique produces minute spheres or tiny 
cells, which helpful in the protection of the active 
phytochemical constituent from destruction by gastric
 
microenvironment 
14
. 
Development and formulation of phytosomes take place 
by taking one molecule of any bifunctional chemical 
compound such as α-lysophosphatidylcholine, 
phosphatidylcholine, phosphatidylethanolamine, α-
phosphatidic acid, with one molecule of active plant 
constituent which has a water soluble chemical class for 
example flavonoids, terpenoides, or aglycon glycosides 
in a solvent which is incapable acts as proton donor i.e. 
aprotic solvent, viz dioxane, acetone, acetonitrile, DMF, 
DMSO. As a result isolation of complexes takes place 
by precipitation with spray drying. The most preferable 
ratio of phospholipid to phytoconstituents is 1:1. 
phospholipids generally used are given here such as α-
phosphatidylcholine, α-phosphatidylethanolamine, α-
phosphatidyl-L-serine, α-phosphatidylinositol, α-
phosphatidic acid, α-phosphatidyl-DL-glycerol, α-
lysophosphatidylcholine, sphingomyelin, cardiolipin but 
most commonly used is soy lecithin (Glycine max) and 
phosphatidylcholine 
15, 16
. Illustration of the development 
of phytosome is shown in the Figure 1. 
Characterization of phytosomes 
To confirm the complex formation between 
phospholipids and herb constituents, spectroscopic 
evaluation, for example, FTIR and 1HNMR, 
13
CNMR to 
reveal the that molecules of the phytoconstituents are 
bonded to phospholipid fraction by means of a chemical 
bond are carried out 
17, 18
 while evaluation of drug 
content can be done by HPLC 
19
 entrapment efficiency 
of the drug by phytosomes can be evaluated by 
ultracentrifugation technique 
20
. Visualization of 
phytosomes can be done using transmission electron 
microscopy (TEM) and scanning electron microscopy 
(SEM) 
21
. Thermal analysis can be done using 
differential scanning calorimetry 
22-24 
Vesicle size and 
zeta potential are determined by dynamic light scattering 
which uses a computerized inspection system and 
photon correlation spectroscopy 
25- 26
. Surface tension 
activity measurement of drug in aqueous solution can be 
measured by the ring method Du Nouy ring tensiometer 
27
.
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Figure1.  Illustration of Phytosome development, evaluation and characterization  
Table1. Details of the investigations based on phytosome technology. 
Formulations
/ Phytosomal 
complex  
Active 
principle/ 
secondary 
metabolites 
from plant 
drugs 
Pharmacokinetics Pharmacology Method of 
preparation 
Dose    Route of 
administration 
Ref 
Ginkgo biloba 
Phytosomes 
Flavonoids Flavonoids of 
GBP stabilize the 
Reactive oxygen 
species 
Cardio-
protective, 
antioxidant 
Phospholipids 
complexation 
100 
mg 
 
Subcutaneous 28 
Ginkgoselect 
Phytosome 
Flavonoids Inhibits lipid 
peroxidation 
stabilize the 
Reactive oxygen 
species 
Hepatoprotective, 
antioxidant 
Phospholipids 
complexation 
25 
and 
50 
mg/ 
kg 
Oral 29 
Silybin 
Phytosome 
Flavonoids Absorption of 
silybin phytosome 
from silybin is 
approximately 
seven times greater 
Hepatoprotective, 
antioxidant for 
liver and skin 
Silybinphosph
olipid 
complexation 
120 
mg 
Oral 30 
Ginseng 
Phytosome 
Ginsenosides Increase 
absorption 
Nutraceutical, 
immunomodulato
r 
Phospholipids 
complexation 
150 
mg 
Oral 31 
Green tea 
Phytosome 
Epigallocatechi
n 
Increase 
absorption 
Nutraceutical, 
antioxidant, 
anticancer 
Phospholipids 
complexation 
50– 
100 
mg 
Oral 31 
Grape seed 
Phytosome 
Procyanidins The blood TRAP 
Total Radical-
trapping  
Antioxidant 
Parameter) were 
significantly 
elevated over the 
control 
antioxidant, 
cardio-protective 
Phospholipids 
complexation 
50– 
100 
mg 
Oral 31 
Hawthorn 
Phytosome 
Flavonoids Increasetherapeuti
c efficacy 
Cardio-
protective, 
antihypertensive 
Phospholipids 
complexation 
100 
mg 
Oral 31 
Quercetin 
Phytosome 
 
Quercetin Exerted better 
therapeutic 
efficacy 
Antioxidant, 
anticancer 
Quercetin 
phospholipid 
complexation 
   _ Oral 32 
 
Table 2: Marketed formulation based on phytosome technology 
Brand name Active principle Drug Delivery system Company Ref. 
Greenselect Phytosome Polyphenols from green tea leaf Phytosome Indena 32 
Leucoselect Phytosome Polyphenols from grape seed Phytosome Indena 32 
Virtiva Phytosome bilobalide from Ginkgo biloba leaf Phytosome Indena 32 
Silymarin Phytosome Silymarin from milk thistle seed Phytosome Indena 32 
Visnadex Phytosome Visnadin from Ammi visnaga umbel Phytosome Indena 32 
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Advantages of phytosomes 
Phytosomes are promising tiny spheres are gaining 
popularity for the delivery of phytoconstituents due to 
their following advantages: 
 Phytosomes increase the absorption of active 
constituents from herbs and hence improve the 
bioavailability. 
 Phytosomes enhances the solubility of bile to the 
chemical constituent, to facilitate the liver targeting.  
 Dose requirement is also reduced by use of 
phytosomal drug delivery system because these 
carriers increase the drug absorption. 
 Improved stability due to chemical bond formation 
between phtyoconstituents bifunctional chemical 
compound such as phosphatidylcholine molecule. 
 Phytosomes are safe to use for transdermal drug 
delivery. 
Disadvantages of phytosomes 
Despites of several advantages of phytosomes some fatal 
disadvantages such as phospholipids (lecithin) can 
induce proliferation on MCF-7 breast cancer cell line 
has been reported 
33
. A major disadvantage of 
phytosome is leaching of the phytoconstituents off the 
‘some’ which reduces the desired drug concentration 
indicating their unstable nature 
34
. 
Phytosomes containing dosage forms 
 
Phytosome preparations can be administered by both 
routes as orally and topically, but to obtain the best 
result regarding bioavailability of formulation, it is 
important to study the dissolution and disintegration 
time of dosage forms while some of the examples of 
dosage forms containing phytosomes are given below 
35
: 
Soft gelatin capsules: Indena recommend a 
granulometry of 100 % < 200 μm in the suspension form 
vegetable or semi-synthetic oils can be used for this 
purpose. 
Hard gelatin capsules: Usually not more than 300 mg in 
a size 0 capsule, without precomresion method is used to 
fill the hard gelatins. 
Tablets: Dry granulation represents the ideal 
manufacturing process to obtain tablets with higher 
unitary doses. Wet granulation is avoided due to adverse 
effect on phospholipid complex. 
Topical dosage forms: The emulsion is used for this 
purpose to obtain the best result from phospholipid 
complex. 
CONCLUSION 
Phytosome technology connects both pharmacokinetics 
and pharmacology of the drug which help in better 
absorption of herbal drug extracts in comparison to other 
traditional dosage forms. Phytosomes offer the best 
bioavailability to the different classes of 
phytoconstituents such as flavonoids, aglycon glycosides 
and terpenoids through the skin and GIT. It also 
improves the intrinsic stability of neutraceuticals. So it 
can be concluded that phytosome is the best tool to 
enhance the absorption of phytoconstituents without any 
adverse drug effect. 
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